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Abstract 
The synthesis of seven iridium complexes [Ir(C^N)2(N^N)][PF6] (AS9-15) designed as dyes for p-type DSSC is 
described. These complexes comprise a 4-(pyrid-2-yl)benzoic acid as the cyclometalating/anchoring ligand with 
different diimine ligands acting as electron accepting ancillary ligands. DFT analysis together with 10 
photophysical investigations reveal how using different π-systems on the ancillary ligand it is possible to tune 
the absorption spectra of these complexes and to enhance the spatial separation between the HOMO and 
LUMO. Computational studies demonstrate an ideal HOMO to LUMO charge transfer directionality for the 
presented [Ir(C^N)2(N^N)]+ frameworks, promoting a favourable hole transfer into the NiO cathode valence 
band upon photoexcitation in p-type DSSC devices. Preliminary tests on NiO-based p-type DSSCs have been 15 
carried out confirming the potential use of complexes AS9-15 as a basis for continued development as DSSC 
chromophores. 
Introduction 
There is currently a growing interest in the development of dye-sensitized solar cells (DSSCs) based on p-type 
inorganic semiconductors (p-SCs) such as nickel oxide. [1] This type of solar cell is based on hole injection into 20 
the valence band of the p-SC from the photoexcited sensitiser. Accordingly, the specific electronic properties of 
the ideal sensitiser for p-SCs significantly differ from those designed for classical Grätzel cells based on the 
sensitization of a n-type semiconductor (n-SC) such as titanium dioxide. In the latter case, the dye must be a 
strong reducing agent in its excited-state in order to inject an electron in the conduction band of the n-SC. [2, 3] 
The electronic requirements of the sensitisers for p-SCs are just the opposite of those for n-SC. In addition, the 25 
 sensitisers must be functionalized with anchoring groups, first to firmly graft them on the semiconductor surface 
and second to provide significant electronic coupling with the semiconductor wavefunction in order to ensure an 
efficient charge tunnelling from the sensitiser excited-state into the semiconductor.[4, 5] For hole injection into 
a p-SC, the electron coupling is optimized when the highest occupied molecular orbital (HOMO) of the dye 
significantly extends over the anchoring groups in order to overlap with the valence band (VB) of the 5 
semiconductor. On the other hand, to minimize the charge recombination, the region of the molecule where the 
LUMO resides, should be kept away from the NiO surface. The attention toward the development of NiO p-type 
DSSCs has increased thanks to their potential use in tandem DSSC, involving the combination of a sensitised 
photocathode with a sensitised photoanode for which, ideally, their absorption should be complementary.  
Although improvements have been made, [6-8] tandem and p-type cells are plagued with low efficiency values, 10 
partly due to rapid (ps timescale [9]) recombination of the photocathode semiconductor hole with the reduced 
dye.[6] In order to overcome this fundamental obstacle in the tandem and p-type system, work has been focused 
on increasing the lifetime of both the reduced dye and charge in the semiconductor, designing chromophores 
that localize the electron farther away from the semiconductor surface.[8, 10-12]  
 15 
Figure 1. Main design of complexes AS9-15, donor fragment (blue), acceptor fragment (red). 
Significantly longer charge separation can be achieved in dyes with charge transfer (CT) character, the longest 
 being with weakly coupled, separate donor and acceptor units. The latter have been long-lived enough to allow 
the use of redox couples other than I3−/I−,[13, 14] most notably cobalt polypyridine complexes that also have 
recently given breakthrough results in TiO2 DSSCs [15, 16] and could then allow extension to p-type or tandem 
cells with Co(III/II) electrolytes. [17]  
Iridium bis cyclometalated hetereleptic complexes are interesting in this regard as they have intrinsic CT excited 5 
state character. The main advantages include the fact that isomers are not a problem as synthesis is 
regioselective which makes CT directionality highly predictable. They also offer photophysical and electronic 
tunability of the ligands for further optimization. Iridium based photosensitisers have recently been reported for 
p-type DSSCs, but with modest results.[18, 19] Moreover, the majority of dyes tested with n- and p-type 
semiconductors are anchored through carboxylic acid groups attached on an ancillary ligand [1, 7, 8, 20] which 10 
is not necessarily optimal for hole injection since being e- withdrawing they generally favour localisation of the 
lowest unoccupied molecular orbital (LUMO) on these ligands. [4, 5]  
The design of a p-type dye reported here (Figure 1) comes mainly from the need to prevent the recombination of 
the injected hole with the excited electron together with a reasonable absorption of the visible light. The 
carboxylate anchoring groups are placed on the electron donating anionic aryl groups. This should maintain 15 
efficient anchoring onto the electrode but ensure localization of the HOMO on these moieties. Use of a neutral 
electron accepting ancillary ligand trans to the anchoring arylcarboxylate rings thus ensures localization of the 
LUMO away from the anchoring groups thereby maximising charge separation and minimising recombination. 
Examples of this Ir(pybaH)2(N^N) type architecture have been previously reported with applications in MOF 
oxygen sensors, luminogenic probes and ion probes but have not been applied as DSSC chromophores. [21-23] 20 
This electron donor moiety is then combined with neutral electron accepting ligands (Figure 2). These range 
from the simple and ubiquitous bipyridine and phenanthroline (AS9 and AS10) to more electronwithdrawing 
ligands such as dipyrido[3,2-a:20-30-c]-phenazine (dppz) (AS11) [24] as well as nitro-substituted bpy ligands 
(AS12 and AS13) to red shift the absorption spectra.[25] We have also included in this series BIAN-type 
[bis(arylimino)acenaphthene] ligands known to yield panchromatic absorption in their Ir(III) cyclometalated 25 
complexes (AS14 and AS15). [26] 
  
 
Figure 2. Iridium biscyclometalated complexes prepared (AS9-15). Ancillary ligands used for p-type complexes 
synthesis (N^N): (AS9) bipyridine; (AS10) phenanthroline; (AS11) dipyrido[3,2-a:20-30-c]-phenazine; (AS12) 
4-nitrobipyridine; (AS13) 4,4’-dinitrobipyridine; (AS14) N,N'-bis(4-methoxyphenylimino)acenaphthene; 5 
(AS15) N,N'-bis(phenylimino)acenaphthene. 
Results & Discussion 
The cyclometalating ligand precursor designed for the reported p-type dyes, has been prepared by oxidizing the 
tolylpyridine to pyridylbenzoic acid (pybaH) with KMnO4. The cyclometalated complexes AS9-15 were 
prepared using a two-step procedure that is depicted in Scheme 1. [27] Iridium (III) chloride and the 4-(2-10 
pyridyl)benzoic acid ligand were combined in ethoxyethanol/water (3:1) and heated to reflux.  
 
Scheme 1. Synthetic route of complexes AS9-15. 
The reaction mixtures are observed to change from dark red to bright orange within 15 to 30 minutes once the 
reaction reaches the point of reflux. To ensure complete consumption of the metal salt, the reactions were heated 15 
for four hours and then allowed to cool to room temperature. The crude dimer solution [Ir(pyba)2Cl]2 was 
 reduced under vacuum to a minimal volume and recrystallised from dichlormethane/hexane, collected by 
filtration and was used without further purification or characterisation. The dimer was then reacted with the 
corresponding ancillary ligand in refluxing dichloromethane/methanol. The product was purified by column 
chromatography on silica and the resulting solids were dissolved in a minimum volume of methanol and 
NH4PF6 was added. The products were recrystallised by addition of diethyl ether to yield from yellow to dark 5 
red solids in modest yields. The complexes [Ir(pyba)2(N^N)]PF6, AS9-15, were then fully characterised using 1H 
and 13C NMR spectroscopy and mass spectrometry.  
The cyclometalation of pyba ligand is evidenced by 1H NMR spectroscopy whereby the corresponding 
complexes show the loss of one proton in the aryl fragment together with a shift to higher field by ~ 0.5 ppm for 
the signals corresponding to the protons adjacent to the coordinated carbon and to the coordinated nitrogen. 10 
In the 1H NMR spectra, AS9-12 and AS14-15 complexes show a single set of resonances for the two 
cyclometalated ligands as consequence of the C2 symmetry of the complexes. The peaks distribution for the 
coordinated diamine ligands shows that half of the ligand is in an unique NMR environment, further reflecting 
this symmetry. Complex AS13 is the only asymmetric complex due to the unsymmetrical NO2-bpy ligand, for 
this reason all its protons exhibit unique resonances.  15 
UV-Visible absorption spectra were recorded for all complexes in aerated acetonitrile solutions at room 
temperature and are presented in Figure 3 with data summarised in Table 1. The absorption spectra of these 
compounds show intense bands in the ultraviolet region between 250 and 350 nm (Figure 3). These bands are 
attributed to spin-allowed π-π* ligand-centred (1LC) transitions. These assignments were made on assessment of 
closely related metal complexes in the literature.[28, 29] The less intense, lower energy absorption features from 20 
350 to 500 nm are due to 1MLCT/1LLCT charge-transfer (CT) transitions. Two types of CT transitions can be 
distinguished in the spectra: bands of moderate intensity between 350 and ~450 nm, assigned to 1MLCT/1LLCT 
transitions, and transitions with weaker intensity (~ 450 – 550 nm), tentatively assigned as being spin forbidden 
3MLCT in character. [30] 
  
Figure 3. Absorption spectra of AS9-15 dyes in acetonitrile. 
AS9 and AS10 have very similar absorption profiles and their absorptions in the visible region is limited to a 
weak band (ε410nm ≈4200 M-1·cm-1) about 410 nm. The absorption profile of AS11 is dominated by a strong 
transition at 274 nm (1LC dppz centred) plus a structured 1MLCT band at 433 nm. Complexes AS12 and AS13 5 
have similar profile and, as expected, the presence of two nitro groups for AS13 helps to enhance the 
absorption, (ε390nm ≈10000 M-1·cm-1 for AS13 vs 6800 M-1·cm-1 for AS12). Complex AS14 has clearly the 
strongest absorption in the visible range within the complexes presented in this work with a strong band across 
430 nm followed by a tail beyond 550 nm. BIAN based ligands have been used previously by Zysman-Colman 
et al. [26] to yield panchromatic absorbing complexes, able to shift the absorption of the complex into the red 10 
and near-IR region. The absorption profile of complex AS15 is clearly affected by the absence of the MeO 
groups on the phenyl rings, in agreement with the results showed by Zysman-Colman et al [26], hence the 
complex absorption profile does not as extensive and is not as intense (ε401nm ≈8100 M-1·cm-1) as that for AS14.  
Table 1. Summarised photophysical absorption and emission data for complexes AS9-15 in aerated acetonitrile. 
 Dye maxabs/ nm (ε / dm3 mol-1 cm-1) maxem/ nm  / ns 
AS9 265 (57200), 289 (43400), 356 (7933), 417 (4250) 508, 535 146 
AS10 267 (53300), 306 (24300), 354 (7390), 405 (4600) 505, 536 144 
AS11 
274 ( 86202), 362 (17538), 381 (16936), 433 
(5380) 
- - 
AS12 267 (46014), 302 (28981), 391 (6871) - - 
AS13 253 (47529), 291 (34300), 390 (10000) - - 
AS14 
265 (56517), 295 (37402), 402 (16210), 431 
(14514) 
- - 
AS15 256 (29463), 295 (19024), 347 (11653), 401 (8139) - - 
 
Normalised emission spectra are presented in Figure 4. Complexes AS9 and AS10 exhibit intense structured 
emission bands, with vibronic progression, with maxima at 508 nm and 535 nm which is characteristic of 
phosphorescent emission from 3MLCT/3ILCT states, dominated by the [Ir(pyba)2] fragment. [21, 28] 
Luminescence lifetimes were also determined in aerated acetonitrile with a value of ca 145 ns for both AS9 and 5 
AS10, consistent with phosphorescent emission from a triplet state. The carboxylic acid EWGs, placed on the 
pyba ligands, bring down in energy the pyba unoccupied orbitals compared to those of ppy, such that the excited 
electron in the emissive excited state must be localised on the pyridyl rings of the pyba instead of the ancillary 
bpy as is the case for [Ir(ppy)2(bpy)]+ which exhibits 3MLCT/3LLCT-based emission at 591 nm. [31] All the 
other complexes are essentially non-emissive and here we expect that the greater electron-withdrawing character 10 
of the ancillary ligands results in 3MLCT/3LLCT states which must decay non-radiatively to the ground state.  
  
Figure 4. Normalised emission spectra for complexes AS9-10 in aerated acetonitrile at RT (λex = 365 nm). 
Electrochemical analysis was complicated by limited solubility of the dyes and therefore did not yield satisfying 
informative results. Some reversible or quasi reversible oxidation waves for AS9-14, corresponding to the one-
electron IrIII/IrIV couple could be observed, however, occurring in the range between +1.02 and +1.19 V (vs 5 
Fc/Fc+) consistent with the expectation of delocalization of the HOMO on the cyclometalating fragment. 
To aid in our understanding of the photophysical properties of the complexes prepared we carried out gas-phase 
density functional theory (DFT) calculations. The orbital analysis reveals the spatial distribution of the HOMO 
and LUMO are perfectly set to promote charge transfer directionality away from the NiO surface and minimize 
the recombination. The HOMO localised on the anchoring ligand, as expected, makes the electronic distribution 10 
on these complexes ideal for their hole injection into the nickel oxide electrode when incorporated in a DSSC 
device.  
Looking at the orbital distribution on complex AS11, it is interesting to note that for the dppz ligand the LUMO 
is localised on the pyrazine rather than on the bpy-like part of the ligand, as previously reported in literature for 
similar dppz complexes, which should lead to increased charge separation.[24] In complexes AS12-13, the 15 
LUMO is delocalised on the dinitro-bpy for AS13 and on the nitro-pyridine fragment for AS12, as consequence 
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 of its asymmetry. The computational data obtained for complexes AS14 and AS15 are in line with those 
reported by Zysman-Colman et al. [26, 32] for [Ir(ppy)2(BIAN)][PF6] and [Ir(ppy)2(MeOBIAN)][PF6]. In 
particular the LUMO is localized on the BIAN fragment and the HOMO on the pyba ligands. 
Despite the emissive state for AS9-10 being 3MLCT/3ILCT in character, the ground state LUMO for these 
complexes is also on the diimine ligand. However, the order of excited states doesn’t necessarily follow the 5 
order of the ground state orbitals associated with them, when their respective unoccupied orbitals are brought 
into close energetic proximity.  
The energy levels of the frontier orbitals are shown in Figure 5 and the corresponding HOMO-LUMO energies 
are reported in Table 2. The calculated HOMO energies remain relatively unchanged as would be expected for 
the consistency of the pyba ligand across the series with a value of about -6.2 eV. However, the introduction of 10 
electron withdrawing nitro substituents on the bipyridyl skeleton in AS12-13, leads to a significant stabilization 
of the LUMO relative to those of complexes AS9 and AS10 by more than 1 eV. For complexes AS14 and AS15, 
the BIAN fragment brings down in energy the LUMO, compared to the bpy analogue, by approximately 0.7 eV. 
 
Table 2 HOMO, LUMO and HOMO-LUMO gap energy values for complexes AS9-15 15 
 
Dye HOMO / eV LUMO / eV Δ / eV 
AS9 -6.04 -2.63 3.41 
AS10 -6.05 -2.65 3.40 
AS11 -6.07 -3.09 2.50 
AS12 -6.16 -3.66 2.37 
AS13 -6.26 -3.90 2.97 
AS14 -5.94 -3.30 2.64 
AS15 -6.02 -3.39 2.63 
 
  
Figure 5. Molecular orbital energy level diagram for complexes AS9-15 
 
Figure 6. Plots of HOMO (bottom) and LUMO (top) orbitals for complexes AS9-15. 
Time-dependent DFT (TDDFT) calculations were carried out on the optimised ground state geometries of each 5 
complex in order to determine vertical excitation energies. From TDDFT analysis (Figure 7 and ESI), the 
predicted transitions correlate well with the experimental spectra. 
The excitations to the S1 state all complexes are primarily HOMOLUMO in character, however, they are of 
low oscillator strength and will therefore contribute little to the observed absorption spectra. The S1 transition 
for complexes AS9-11 takes place below 500 nm, whereas the S1 for all the other complexes, occurs beyond 630 10 
nm (see ESI). The major transitions observed for all complexes between 350 and 500 nm are primarily of 
 1MLCT character (see ESI), with generally charge transfer from Ir/aryl to ancillary ligand. Below 300 nm most 
of the transitions are 1LC in character, for example AS11 shows a transition at 283 nm with a high oscillator 
strength which is ILCT in character with charge transfer from the distal phenazine to the proximal phenantroline 
moieties of the dppz ligand. Only AS14 shows a strong transition beyond 450 nm of 1MLCT/1ILCT character, 
with a substantial contribution of the MeO-BIAN fragment. 5 
  
Figure 7. TDDFT calculated transitions for complexes AS9-15 with experimental spectra overlaid. 
The photovoltaic properties of the complexes as dyes in p-type NiO based DSSC were evaluated in preliminary 
test devices. Complex AS15 wasn’t tested because of its low solubility. The dye coated film was prepared using 
a water/ethanol solution of NiCl2 and a triblock co-polymer, F108. Platinised fluorine-doped tin oxide (FTO) 10 
 glass was used as the counter electrode and the electrolyte was a solution of 0.1 M I2 and 1.0 M LiI in 
acetonitrile . The cells were thermally sealed before measurements. Photovoltaic measurements were performed 
on an AM 1.5 solar simulator (100 mW cm-2) and the incident light was calibrated by using a Si photodiode 
reference. JV curves were obtained by applying an external bias to the cells and measuring the generated 
photocurrent with a Keithley digital source meter. 5 
Figure 8 reports the IPCE data for complexes AS9-14, which  all exceed the IPCE for un-dyed NiO ; this 
suggests they each photosensitise NiO. The IPCE values are between 10 and 25% and their profiles reflect the 
corresponding absorption spectra of the dyes. Unfortunately the presented dyes have their main absorption 
bands at or below ~ 500 nm and so the IPCE traces similarly tail off in this region. Only AS13-14, which 
present the highest extinction coefficients in the visible region, generate reasonable IPCE values. 10 
 
Figure 8. IPCE spectra for p-type cells sensitised using iridium complexes AS9-14. 
All the applied complexes, under irradiation, were able to generate a photocurrent. The photovoltaic 
performances of solar cells based on these iridium complexes AS9-14 are summarised in Table 3. Figure 9 
shows the current–voltage characteristics of the dyes under AM 1.5. Both IPCE and efficiency values for AS11 15 
 and AS12 may have been affected by their low solubility as a dilute dye solution  presumably limits the dye 
loading on the immersed electrodes. As expected from their very similar structures, AS9 and AS10 showed 
nearly identical results in terms of IPCE and efficiency. Complexes AS13 and AS14 showed the best 
efficiencies of 0.032% and 0.043% respectively, attributable to their enhanced absorption in the visible 
spectrum compared to the rest of the series. The reported efficiencies seem to follow the trend of IPCE 5 
intensities shown in Figure 8.  
Table 3. Photovoltaic parameters of tested dyes. 
Dye Jsc / mA cm-2 Voc / V FF / % η / % 
AS9 0.68 0.09 36.6 0.022 
AS10 0.66 0.09 37.6 0.022 
AS11 0.45 0.07 38.1 0.013 
AS12 0.36 0.09 40.1 0.013 
AS13 0.82 0.10 38.7 0.032 
AS14 1.12 0.10 36.8 0.043 
 
Figure 9. Current-Voltage curves DSSC constructed using iridium complexes AS9-14. 
 Conclusions 
We have prepared and characterised, by 1H and 13C NMR spectroscopy, mass spectrometry and investigated the 
photophysics by UV-Visible absorption and emission spectroscopy, seven new iridium(III) dyes with various 
ancillary ligands. Computational calculations were fundamental tools in the theoretical characterisation of the 
new complexes and in the prediction and explanation of their proprieties. Diimine complexes show good tuning 5 
of absorption wavelengths and HOMO-LUMO gap, and thanks to their design, these complexes show spatial 
charge transfer directionality together with energy levels in accordance with their intended application in p-
DSSC. The use of these complexes as sensitisers in DSSC devices has been investigated. All tested complexes 
achieved modest efficiencies with AS13 and AS14 showing the best efficiencies of 0.032% and 0.043% 
respectively. these are nevertheless encouraging results when related to the 0.068% efficiency reported for 10 
[Ir(ppy)2(N^N)]+ -based complexes, bearing methyl phosphonic acid as anchoring groups, by Gennari et al. [18] 
and to the 0.020% previously reported by our group, using the coumarin C6 complex [Ir(C6)2(dcb)]+.[19] The 
methodology reported here will allow for facile tuning of photophysical and photovoltaic properties and produce 
dyes with greater ease than existing ruthenium based systems. Results are encouraging for the development of a 
new generation of p-type dyes based on this general design. Future research will focus on improving on these 15 
initial studies and increasing the light absorbing properties of these dyes together with the substitution of the 
triiodide/iodide electrolyte for a one-electron, outer sphere redox couple such as cobalt polypyridyl complexes, 
in order to relieve the constraint that the complexities of the iodine-based system impose on the energetic 
requirements of the dye. [33]  
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Materials and general synthetic procedures 25 
Chemicals were purchased from Aldrich and Acros, iridium was purchased from Precious Metals Online 
 (Australia) and used as received. All complexation reactions were carried out under nitrogen. Dppz 
dipyrido[3,2-a:20-30-c]-phenazine [34], 4-nitro-bipyridine and 4,4’-dinitro-bipyridine [35, 36] , BIAN 
[bis(arylimino)acenaphthene] [37] were prepared according to literature methods. 
All the compounds prepared in this work were characterized by 1H NMR and 13C NMR spectrometry; spectra 
were obtained on a Bruker Advance 400 MHz instrument. Mass spectrometry data were collected on a Bruker 5 
MicroTOF-Q instrument and Agilent 6210 TOF MS. UV-Visible absorption spectra were recorded on an 
Agilent Cary 60 UV-Vis spectrophotometer and corrected emission spectra were recorded on a Horiba 
Fluoromax-4 Spectrofluorometer. Luminescent lifetime measurements were carried out using an Edinburgh 
Instruments Mini-Tau spectrometer.  
Dye sensitised solar cell fabrication 10 
NiO electrodes were made by applying the precursor solution described in previous literature [38] onto 
conducting glass substrates (Pilkington TEC15, sheet resistance 15 Ω/sq) by doctor blade using adhesive tape 
(3M) as spacer (0.2 cm2 active area), followed by sintering in a NaberthermB150 oven at 450 °C for 30 min. 
NiO films were immersed in dye solutions (0.3 mM) for 12 h. The dyed NiO electrode was assembled face-to-
face with a platinised counter electrode (Pilkington TEC8, sheet resistance 8 Ω/sq) using a 30 μm thick 15 
thermoplastic frame (Surlyn 1702). The electrolyte, containing LiI (1.0 M) and I2 (0.1 M) in acetonitrile, was 
introduced through the predrilled hole in the counter electrode, which was sealed afterward. The active area was 
0.25 cm2. 
Computational methods 
DFT calculations were carried out using the NWChem 6.3 software package [39]. Calculations were carried out 20 
using the B3LYP hybrid functional (20% Hartree–Fock), [40] Stuttgart relativistic small core ECP [41] for 
transition metals and 6-311G* basis sets [42] for all other atoms. Molecular structures and molecular orbitals 
were visualized using the ccp1 graphical user interface. The ground state geometries of all complexes were first 
optimized and molecular orbital energies determined. TDDFT calculations were then used at the ground state 
geometries to derive vertical excitation energies and hence simulated absorption spectra. TDDFT calculations 25 
 on optimised structures in CH3CN by using the COSMO solvation model, [43] built in NWChem software, were 
used to obtain the electronic spectra and molecular orbital energy levels.  
 
Synthesis of 4-(2-pyridyl)benzoic acid (pyba) 
This synthetic procedure was adapted from ref [44]. Tolyl-pyridine was oxidized with KMnO4 as follows: a 5 
mixture of tolyl-pyridine (0.514 g) and KMnO4 (1.54 g) in water 50 mL was heated at 70°C for 24 h. After 
filtration of the reaction mixture and washing the filtrate with aqueous NaOH (1M, 5 mL), the combined water 
fraction were collected and washed three times with CHCl3 to remove unconverted starting material. The 
aqueous solution was neutralized with HCl (1M) and concentrated (30 mL). After acidifying to pH 4, the 
precipitate was collected, washed with ethanol and dried in vacuum yielding a white powder. (Yield 85%)  10 
1H NMR (400 MHz, CD3OD) δ:8.57 (d, 3J = 4.46, 1H, Py-H); 8.05 (d, 3J = 8.23, 2H, Ar-H); 7.97 (d, 3J = 8.23, 
2H, Ar-H); 7.87 (d, 3J = 3.43, 1H, Py-H); 7.37-7.33 (m, 2H, Py-H). 
13C {1H} NMR (400 MHz, DMSO-d6): 168.04, 154.59, 148.75, 141.78, 139.90, 131.51, 130.44, 129.98, 127.55, 
124.50, 122.69. 
HRMS (ESI) m/z calcd 199.0633 for C12H9NO2, found 200.0706 (M+H)+ 15 
Synthesis of [Ir(4-(2-pyridyl)benzoic acid)2Cl]2 
353 mg of IrCl3·3H2O (1 mmol) were dissolved in 35 mL 2-ethoxyethanol:water 3:1 in 2 necked round bottom 
flask and degassed with N2 at 80°C for 20 minutes. 2 equivalents (400 mg) of 4-(2-pyridyl)benzoic acid were 
added and heated to reflux temperature for 4 hours. The solution was reduced to a minimal volume and 
recrystallized from DCM/Hexane. The dimer was used without any further characterization or purification. 20 
Synthesis of [Ir(pyba)2(2,2'-bipyridine)]PF6 (AS9) 
2,2'-bipyridine (0.025 g, 0.16 mmol) was dissolved in DCM:MeOH 2:1 (6 mL) and [Ir(pyba)2(Cl)]2 (0.100 g, 
 0.08 mmol) was added. The mixture was heated at reflux under nitrogen atmosphere, in the dark. After 6 hrs, the 
yellow solution was cooled to room temperature. The crude solid was purified by column on silica eluted with 
MeCN:H2O:KNO3 7:1:0.5. The yellow fraction was dried under vacuum, redissolved in acetonitrile and filtered. 
The solution was dried again and the solid was dissolved in a minimal amount of methanol and NH4PF6 (130 
mg, 0.9 mmol) was added allowed to stir overnight. The solution was left in the fridge for two hours, 5 
recrystallised with ether and then filtered on sintered glass. A yellow powder was collected by filtration. (42 mg, 
yield 30%) 
1H NMR (400 MHz, CD3CN) δ:8.55 (d, 3J = 8.36, 2H, Bpy-H); 8.20 (d, 3J = 8.36, 2H, Pyba-H); 8.16 (t, 3J = 
6.18, 2H, Bpy-H); 8.00-7.94 (m, 4H, Bpy-H&Pyba-H); 7.93 (d, 3J = 8.36, 2H, Pyba-H); 7.71-7.67 (m, 4H, 
Pyba-H); 7.51 (t, 3J = 6.84, 2H, Bpy-H); 7.17 (t, 3J = 6.59, 2H, Pyba-H); 6.89 (s, 2H, Pyba-H). 10 
13C {1H} NMR (400 MHz, CD3CN): 167.15, 166.58, 156.29, 151.48, 150.21, 149.79, 149.29, 140.14, 139.61, 
132.63, 131.29, 129.10, 125.32, 125.30, 125.26, 124.85, 121.70. 
MS (ESI) m/z calcd for [C34H24IrN4O4] + 745.1426, found 745.1427 (M+). 
Synthesis of [Ir(pyba)2(1,10-phenanthroline)]PF6 (AS10) 
The synthetic procedure was the same as that for AS9, except that 1,10-phenanthroline (0.027 g, 0.16 mmol), 15 
which replaced 2,2'-bipyridine, was used. The resulting product was purified and precipitated as for AS9, 
yielding a bright yellow powder. (20 mg, yield 13%) 
1H NMR (400 MHz, CD3CN) δ:8.72 (dd, 3J = 8.23, 4J = 1.27, 2H, Phen-H); 8.31 (dd, 3J = 8.5, 4J = 1.27, 2H, 
Phen-H); 8.26 (s, 2H, Phen-H); 8.19 (d, 3J = 8.00, 2H, Pyba-H); 7.96 (d, 3J = 8.23, 2H, Pyba-H); 7.90 (td, 3J = 
7.30, 4J = 1.51, 2H, Phen-H); 7.86 (dd, 3J = 8.24, 4J = 5.03, 2H, Phen-H); 7.72 (dd, 3J = 8.23, 4J = 1.62, 2H, 20 
Pyba-H); 7.51 (dd, 3J = 5.45, 4J = 0.70, 2H, Pyba-H); 7.00 (td, 3J = 5.33, 4J = 1.27, 4H, Pyba-H)  
13C {1H} NMR (400 MHz, CD3CN) δ:166.62, 152.12, 150.38, 149.55, 149.29, 147.27, 139.50, 139.31, 132.83, 
132.23, 128.86, 127.98, 127.41, 126.65, 125.21, 125.15, 124.92, 121.6. 
 MS (ESI) m/z calcd for [C36H24IrN4O4] + 769.142, found 769.2015 (M+). 
Synthesis of [Ir(pyba)2(2,5-bis(2-pyridyl)pyrazine)]PF6 (AS11) 
The synthetic procedure was the same as that for AS9, except that 2,5-bis(2-pyridyl)pyrazine (0.043 g, 0.154 
mmol), which replaced 2,2'-bipyridine, was used. The resulting product was purified and precipitated as for 
AS9, yielding a dark yellow powder. (28 mg, yield 17.8 %) 5 
1H NMR (400 MHz, CD3CN) δ:9.80 (d, 3J = 8.22, 2H, Dppz-H); 8.51-8.47 (m, 2H, Dppz-H); 8.41 (d, 3J = 4.40, 
2H, Dppz-H); 8.23 (d, 3J = 8.03, 2H, Pyba-H); 8.18-8.14 (m, 2H, Dppz-H); 8.04-7.90 (m, 6H, Dppz-H&Pyba-
H); 7.75 (d, 3J = 8.22, 2H, Pyba-H); 7.71 (d, 3J = 4.97, 2H, Pyba-H); 7.05 (t, 3J = 6.50, 2H, Pyba-H); 7.00 (s, 
2H, Pyba-H). 
[Low solubility] 13C {1H} NMR (400 MHz, CD3CN): 166.05, 152.80, 150.07, 149.61, 148.92, 148.44, 142.80, 10 
139.93, 139.11, 135.38, 132.57, 132.25, 131.34, 129.65, 128.39, 124.77, 124.67, 124.50, 121.16.  
MS (ESI) calcd for [C42H26IrN6O4]+ 871.1644, found 871.1631 (M+). 
Synthesis of [Ir(pyba)2(4-nitro-2,2'-bipyridine)]PF6 (AS12) 
The synthetic procedure was the same as that for AS9, except that 4-nitro-2,2'-bipyridine (0.031 g, 0.16 mmol), 
which replaced 2,2'-bipyridine, was used. The resulting product was purified and precipitated as for AS9, 15 
yielding an orange powder. (28.6 mg, yield 20%) 
1H NMR (400 MHz, CD3CN) δ:9.81 (d, 3J = 1.88, 1H, Bpy-H); 8.77 (d, 3J = 8.15, 1H, Bpy-H); 8.28 (d, 3J = 
5.95, 1H, Bpy-H); 8.26-8.20 (m, 3H, Bpy-H); 8.10 (dd, 3J = 5.95, 4J = 1.88, 1H, Bpy-H); 8.04 (d, 3J = 5.33, 1H, 
Bpy-H); 8.01-7.92 (m, 4H, Pyba-H); 7.73-7.66 (m, 4H, Pyba-H); 7.60 (t, 3J = 6.42, 1H, Bpy-H); 7.18 (t, 3J = 
6.42, 1H, Pyba-H); 7.16 (t, 3J = 6.58, 1H, Pyba-H); 6.89 (d, 3J = 1.10, 1H, Pyba-H); 6.85 (d, 3J = 1.10, 1H, 20 
Pyba-H). 
[Low solubility] 13C {1H} NMR (400 MHz, CD3CN) δ:166.58, 165.90, 165.79, 159.63, 154.78, 154.24, 153.78, 
 151.35, 149.95, 149.79, 148.16, 148.47, 139.91, 139.33, 139.31, 132.14, 131.90, 130.94, 129.69, 126.13, 
124.90, 124.84, 124.79, 124.77, 124.66, 124.58, 121.62, 121.31, 118.27.  
MS (ESI) calcd for [C34H23IrN5O6]+ 790.17, found 790.1271 (M+). 
Synthesis of [Ir(pyba)2(4’,4-dinitro-2,2'-bipyridine)]PF6 (AS13) 
The synthetic procedure was the same as that for AS9, except that 4’,4-dinitro-2,2'-bipyridine (0.039 g, 0.16 5 
mmol), which replaced 2,2'-bipyridine, was used. The resulting product was purified and precipitated as for 
AS9, yielding a dark red powder (40.3 mg, yield 25%) 
1H NMR (400 MHz, CD3CN) δ:9.43 (s 2H, Bpy-H); 8.34 (d, 3J = 6.03, 2H, Bpy-H); 8.23 (d, 3J = 8.03, 2H, 
Pyba-H); 8.18 (dd, 3J = 6.03, 4J = 1.67, 2H, Bpy-H); 8.00 (t; 3J = 8.03, 2H, Pyba-H); 7.98-7.95 (m, 2H, Pyba-
H); 7.73 (d, 3J = 8.03, 2H, Pyba-H); 7.67 (d, 3J = 5.36, 2H, Pyba-H); 7.18 (t, 3J = 6.19, 2H, Pyba-H); 6.85 (s, 10 
2H, Pyba-H). 
[Low solubility] 13C {1H} NMR (400 MHz, CD3CN) δ:165.63, 157.76, 157.51, 155.05, 154.17, 154.13, 150.07, 
150.04, 139.62, 139.22, 131.92, 131.12, 124.94, 124.92, 122.78, 121.48, 119.56. 
MS (ESI) m/z calcd for [C34H22IrN6O8]+ 835.1128, found 835.1135 (M+). 
Synthesis of [Ir(pyba)2(N,N'-bis(4-methoxyphenylimino)acenaphthene)]PF6 (AS14) 15 
The synthetic procedure was the same as that for AS9, except that 4-MeOPh-BIAN (0.063 g, 0.16mmol), which 
replaced 2,2'-bipyridine, was used. The resulting product was purified and precipitated as for AS9, yielding a 
brown powder. (35 mg, yield 21%) 
1H NMR (400 MHz, CD3CN) δ: 8.84 (d, 3J = 5.12 Hz, 2H, Pyba -H); 8.31 (d, 3J = 8.28 Hz, 2H, BIAN-H); 8.07-
8.01 (m, 4H, Pyba -H); 7.60 (t, 3J = 7.84 Hz, 2H, BIAN-H); 7.52 (d, 3J = 7.68 Hz, 2H, Pyba-H); 7.47-7.41 (m, 20 
4H, Pyba-H); 7.35 (d, 3J = 7.56 Hz, 2H, BIAN-H); 6.99 (bs, 2H, BIAN-H); 6.73 (s, 2H, Pyba-H); 6.63 (bs, 4H, 
BIAN-H); 6.11 (bs, 2H, BIAN-H); 3.74 (s, 6H, BIAN-CH3). 
 13C {1H} NMR (400 MHz, CD3CN) δ:173.23, 165.73, 159.33, 151.64, 148.12, 147.63, 139.34, 137.77, 131.92, 
131.54, 131.28, 130.27, 128.92, 127.27, 125.12, 124.06, 123.84, 123.80, 120.66, 114.69, 55.34.  
MS (ESI) m/z calcd for [C50H34IrN4O6]+ 981.2264, found 981.2380 (M+). 
Synthesis of [Ir(pyba)2(N,N'-bis(phenylimino)acenaphthene)]PF6 (AS15) 
The synthetic procedure was the same as that for AS9, except that Ph-BIAN (0.054 g, 0.16mmol), which 5 
replaced 2,2'-bipyridine, was used. The resulting product was purified and precipitated as for AS9, yielding a 
dark green powder. (35 mg, yield 21%)   
1H NMR (400 MHz, DMSO-d6) δ:9.06 (d, 3J = 5.49, 2H, Pyba-H); 8.40 (d, 3J = 8.30, 2H, BIAN-H); 8.24 (d, 3J 
= 7.60, 2H, Pyba-H); 8.18 (d, 3J = 7.04, 2H, Pyba-H); 7.71-7.64 (m, 2H, BIAN-H); 7.63-7.53 (m, 4H, Pyba-H); 
7.30-7.18 (m, 8H, Pyba-H&BIAN-H); 7.15-7.08 (m, 2H, BIAN-H); 7.03-6.95 (m, 2H, BIAN-H); 6.53 (d, 3J = 10 
6.25, 2H, Pyba-H); 6.05-5.93 (m, 2H, BIAN-H). 
[Low solubility] 13C {1H}  NMR not recorded 
HRMS (ESI) m/z calcd for [C48H32IrN4O4]+ 921.2052, found 921.2204 (M+) 
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